Comprehensive Hematological Malignancy Panel

Comprehensive Hematological Malignancy Panel is tailored to detect genetic changes( mutations) responsible for causing common blood cancers (leukemia) such as Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPN), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), and Juvenile Myelomonocytic Leukemia (JMML). This test may help your doctor detect the type of blood cancer you may have, the likely outcome of your disease, to formulate your treatment and care plan for the purpose of combating the blood cancer. Lifestyle risk factors are attributed to cancer burden therefore, making healthy lifestyle changes may help reduce the risk of developing blood cancer.